Search for Clinical Trial Results
Amyloidosis, Familial - 33 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy Condition:
|
Active, not recruiting |
Study Name: Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy Condition:
|
Completed |
Study Name: The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin Condition: Transthyretin Familial Amyloid Polyneuropathy Date: 2011-09-13 Interventions: Drug: tafamidis tafamidis meglumine 20 mg QD Other N |
Completed |
Study Name: The Effect of Diflunisal on Familial Transthyretin Amyloidosis Condition: Amyloidosis Date: 2011-09-09 Interventions: Drug: Diflunisal Film-coated tablet, 250 mg twice daily, orally for approximately 2 years |
Withdrawn |
Study Name: F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH) Condition: Cerebral Amyloid Angiopathy Date: 2011-06-21 |
Completed |
Study Name: Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis Condition: Transthyretin Amyloidosis Date: 2010-07-27 Interventions: Drug: Doxycycline + Tauroursodeoxycholic acid doxycycline 100 mg twice a day for 12 months; tauroursodeo |
Completed |
Study Name: An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy Condition:
Date: 2008-11-13 Interventions: Drug: Fx-1006A Fx-1006A 20mg soft gelatin capsule administered orally once daily (at the same time each |
Completed |
Study Name: The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis Condition: Transthyretin-associated Amyloidosis With Polyneuropathy Date: 2008-02-27 Interventions: Drug: Fx-1006A During Part 1, patients will receive Fx-1006A 20mg soft gelatin capsules once daily (at t |
Recruiting |
Study Name: Transthyretin-Associated Amyloidoses Outcome Survey (THAOS) Condition:
Date: 2008-02-25 Interventions: Other: None. Observational Study. |
Completed |
Study Name: Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy Condition:
Date: 2003-03-07 Interventions: Drug: NC-758 (Anti amyloidotic [Aß] agent) |